The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma
The purpose of this study is to measure the expression of microRNA-4463 and microRNA-6087 between normal persons and patients with hepatocellular carcinoma (HCC), and to clarify the meaning of them in the prognosis evaluation in HCC. Forty-five samples from healthy people and patients, who had been...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304217300260 |
id |
doaj-13d785fe4cfc4b8ab63ef43f9b250439 |
---|---|
record_format |
Article |
spelling |
doaj-13d785fe4cfc4b8ab63ef43f9b2504392020-11-24T21:54:45ZengElsevierGenes and Diseases2352-30422017-06-014211612210.1016/j.gendis.2017.03.003The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinomaTian Hu0Jincheng Li1Chuhong Zhang2Xiu lv3Sai Li4Sha He5Hanxing Yan6Yixi Tan7Mingsheng Lei8Meiling Wen9Jianhong Zuo10The Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaMedical School, Shaoyang University, Shaoyang, Hunan, 422000, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaDepartment of Respiratory and Critical Care Medicine, Zhangjiajie City Hospital, Zhangjiajie, Hunan, 427000, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, 421001, ChinaThe purpose of this study is to measure the expression of microRNA-4463 and microRNA-6087 between normal persons and patients with hepatocellular carcinoma (HCC), and to clarify the meaning of them in the prognosis evaluation in HCC. Forty-five samples from healthy people and patients, who had been diagnosed with hepatocellular carcinoma before any treatment, were collected to study respectively. Real-time PCR was used to detect the expression of miRNA-4463 and miRNA-6087 in the serum of control group and hepatocellular carcinoma patients. The expression of miR-4463 in the serum of HCC patients was significantly higher than that in control group (P < 0.05), and the expression level was independent of gender, tumor size, cell types, stages, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL) and HBsAg status (P > 0.05). But there was a significant difference of different level of AFP in HCC (P < 0.05), and the difference between the group of AFP lower than 400 ug/l and the control group is statistically significant (P < 0.05). Besides, the survival time had showed a significant difference at the high and low expression levels (P < 0.05). But the expression level of miRNA-6087 was no difference in HCC and control group. The disorder of miRNA-4463 occurred in HCC, even the AFP level doesn't rises. What's more, patients who get the high level of miRNA-4463 seem to have a shorter survival time. And it contributes great to the prognostic evaluation. This is the first study to illustrate the potential significance of miRNA-4463 in the prognosis in HCC.http://www.sciencedirect.com/science/article/pii/S2352304217300260Hepatocellular carcinomamalignant tumorsmicroRNA-4463microRNA-6087miR-4463Prognostic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tian Hu Jincheng Li Chuhong Zhang Xiu lv Sai Li Sha He Hanxing Yan Yixi Tan Mingsheng Lei Meiling Wen Jianhong Zuo |
spellingShingle |
Tian Hu Jincheng Li Chuhong Zhang Xiu lv Sai Li Sha He Hanxing Yan Yixi Tan Mingsheng Lei Meiling Wen Jianhong Zuo The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma Genes and Diseases Hepatocellular carcinoma malignant tumors microRNA-4463 microRNA-6087 miR-4463 Prognostic |
author_facet |
Tian Hu Jincheng Li Chuhong Zhang Xiu lv Sai Li Sha He Hanxing Yan Yixi Tan Mingsheng Lei Meiling Wen Jianhong Zuo |
author_sort |
Tian Hu |
title |
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
title_short |
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
title_full |
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
title_fullStr |
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
title_full_unstemmed |
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
title_sort |
potential value of microrna-4463 in the prognosis evaluation in hepatocellular carcinoma |
publisher |
Elsevier |
series |
Genes and Diseases |
issn |
2352-3042 |
publishDate |
2017-06-01 |
description |
The purpose of this study is to measure the expression of microRNA-4463 and microRNA-6087 between normal persons and patients with hepatocellular carcinoma (HCC), and to clarify the meaning of them in the prognosis evaluation in HCC. Forty-five samples from healthy people and patients, who had been diagnosed with hepatocellular carcinoma before any treatment, were collected to study respectively. Real-time PCR was used to detect the expression of miRNA-4463 and miRNA-6087 in the serum of control group and hepatocellular carcinoma patients. The expression of miR-4463 in the serum of HCC patients was significantly higher than that in control group (P < 0.05), and the expression level was independent of gender, tumor size, cell types, stages, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL) and HBsAg status (P > 0.05). But there was a significant difference of different level of AFP in HCC (P < 0.05), and the difference between the group of AFP lower than 400 ug/l and the control group is statistically significant (P < 0.05). Besides, the survival time had showed a significant difference at the high and low expression levels (P < 0.05). But the expression level of miRNA-6087 was no difference in HCC and control group. The disorder of miRNA-4463 occurred in HCC, even the AFP level doesn't rises. What's more, patients who get the high level of miRNA-4463 seem to have a shorter survival time. And it contributes great to the prognostic evaluation. This is the first study to illustrate the potential significance of miRNA-4463 in the prognosis in HCC. |
topic |
Hepatocellular carcinoma malignant tumors microRNA-4463 microRNA-6087 miR-4463 Prognostic |
url |
http://www.sciencedirect.com/science/article/pii/S2352304217300260 |
work_keys_str_mv |
AT tianhu thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT jinchengli thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT chuhongzhang thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT xiulv thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT saili thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT shahe thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT hanxingyan thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT yixitan thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT mingshenglei thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT meilingwen thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT jianhongzuo thepotentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT tianhu potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT jinchengli potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT chuhongzhang potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT xiulv potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT saili potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT shahe potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT hanxingyan potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT yixitan potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT mingshenglei potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT meilingwen potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma AT jianhongzuo potentialvalueofmicrorna4463intheprognosisevaluationinhepatocellularcarcinoma |
_version_ |
1725866003272826880 |